We conducted a retrospective audit of 285 adult elective microlaryngoscopy cases in our institution over a three-and-a-half year period. Conventional anaesthesia with intubation and mechanical ventilation was the most common technique, used in 71% of cases. Tubeless spontaneous ventilation during total intravenous anaesthesia with a target-controlled infusion of propofol (SVTCI) was the most common alternative. Spontaneous ventilation with target-controlled infusion was used for 79 (27.7%) anaesthetic inductions and was continued through the maintenance phase for 60 patients (21.1%). Jet and intermittent ventilation were both used infrequently (1% each). The most common SVTCI technique since 2013 involved adjusting the target-controlled infusion rate during induction using a formula we developed based on intermittently increasing the target rate, such that the predicted plasma concentration minus the predicted effect site concentration was maintained at 1 μg/ml. We found that this method maintained ventilation during induction more reliably than other SVTCI strategies, and was associated with fewer complications than other spontaneous ventilation techniques or mechanical ventilation: it was associated with only one (3.1%) failed induction and one (3.9%) episode of apnoea. Jet ventilation was associated with the most severe complications, including two cases of barotrauma.
. Each technique has its own well-documented advantages and disadvantages, with none completely satisfying both surgical and anaesthetic interests [2] [3] [4] [5] [6] . Spontaneous ventilation (SV) has several surgical and anaesthetic advantages during microlaryngoscopy. It is completely tubeless, which provides optimal exposure to the airway 6 . This is particularly advantageous for posterior glottic or subglottic lesions, which can be more difficult to access, even with jet ventilation 4, 7 . It also facilitates dynamic airway assessment, which allows distinction between fixed and functional obstructive lesions 1, 2, 6 . In contrast to jet ventilation (JV), intermittent ventilation (IV) and apnoeic oxygenation (AO) respectively, SV has no risk of barotrauma, requires no surgical interruption and is compatible with use of laser 1, 3, 6, 8, 9, 10 . The ability to provide total intravenous anaesthesia using propofol target-controlled infusion (TCI) and maintain SV and oxygenation with no artificial airway is useful in cases of airway stenosis. These lesions can challenge conventional difficult airway management due to the potential for impossible intubation or a requirement for surgical rescue 11 . Maintenance of SV during the induction provides a margin of safety that may be beneficial for cases with significant airway obstruction, although there are conflicting opinions about this 7, 12, 13 . Despite these benefits, the use of SV in adult microlaryngoscopy has generally been regarded as less favourable than other open airway techniques such as JV, IV or AO 3, 4, 8 . It has been associated with patient reactivity, poor operating conditions, and greater difficulty in achieving the required depth of anaesthesia for patients to tolerate microlaryngoscopy while simultaneously maintaining adequate ventilation and haemodynamic stability 1, 6, 14, 15 . Spontaneous ventilation using propofol TCI (SVTCI) has been used regularly for adult microlaryngoscopy at our institution for several years. It has become our most common "open" airway technique, and has largely replaced the use of jet ventilation. Different anaesthetic strategies of SVTCI can broadly be divided into groups that use propofol only and those that co-infuse opioids (e.g. alfentanil, remifentanil) from the start of the induction. Careful increases in the propofol target concentration are required to ensure smooth anaesthetic induction while at the same time maintaining SV. Unfortunately there are no guidelines on how this is best achieved. Therefore, in an attempt to improve the reliability of this technique, the authors introduced a standardised method of propofol-only SVTCI in April 2013. This method uses a formula (Cp -Ce = 1), based on the predicted plasmasite (Cp) and effect-site (Ce) concentrations for Marsh model TCI, to guide the increase in infusion rates during anaesthetic induction. This Cp -Ce = 1 formula has since become the most common method of propofol-only SVTCI in our institution and has been used for an expanding casemix of surgical pathology and procedures.
The purpose of this audit was to examine the overall success and safety of the use of SVTCI for microlaryngoscopy at our institution. Specifically we wanted to measure the success, failure, and complication rates for the group of patients receiving propofol-only SVTCI (SVTCI ) and compare this with the other SVTCI subgroups.
Methods
The study was conducted at the Princess Alexandra Hospital, which is a teaching hospital in Brisbane, Australia, with an adult tertiary ENT/Head and Neck surgical centre. Human Research Ethics Committee approval from the Metro South Hospital and Health Service (Brisbane, Queensland, Australia) was obtained prior to commencing the study (HREC/14/QPAH/170).
Design
A retrospective audit of the anaesthetic records for all elective microlaryngoscopy cases between October 2011 and February 2015 was performed. The aim of this analysis was to identify the number of cases where SVTCI was used during the induction or maintenance phases of anaesthesia. These cases were then categorised into different subgroups based on the particular method of SVTCI used. Outcome measures were recorded for the different subgroups of SVTCI and also for the non-SVTCI groups.
Data Collection
The elective microlaryngoscopy cases for the retrospective period were identified using the hospital Operating Room Information Management System (ORMIS) database. Included cases required identification of microlaryngoscopy and/ or suspension laryngoscopy in the procedure description. Emergency cases, privately billed cases, panendoscopy without suspension laryngoscopy, and cases involving a pre-existing tracheostomy were excluded. The electronic anaesthetic record for each microlaryngoscopy case was manually reviewed to extract the anaesthetic data. Our hospital utilises an electronic Automated Anaesthetic Record Keeping (AARK-Winchart) system, which we accessed online. When required, the physical chart record and surgical notes were reviewed to clarify the anaesthetic technique (<10% of cases overall).
All of the SVTCI Cp-Ce=1 cases were managed by one of the authors or a trainee under their direct supervision. Multiple different anaesthetists and trainees were involved in the other SVTCI and non-SVTCI techniques.
Description of the SVTCI Cp-Ce=1 Protocol
The authors' standardised method of propofol-only SVTCI (SVTCI Cp-Ce=1 ) involved a slow stepwise increase in the predicted plasma-site concentration target (Cpt) during the induction. The Marsh pharmacokinetic model TCI using Cpt was programmed into an Alaris® PK syringe pump (Carefusion, Basingstoke, UK) using total body weight (up to a maximum of 100 kg). The starting Cpt was typically set at 3 μg/ml and the infusion was commenced. The Cpt was increased when the rising predicted effect-site concentration (Ce), as displayed on the pump, reached a point 1 μg/ml below the Cp (i.e. Cp -Ce = 1 μg/ml). At this point the Cpt was typically increased by 1.0 μg/ml and the Cp -Ce cycle repeated again. The TCI rate was increased in this stepwise manner until the Ce reached its designated endpoint (usually 6 μg/ml for airway instrumentation). At this final point, the Ce would then be allowed to equilibrate with the Cp ( Figure  1 ) with spontaneous ventilation maintained. SVTCI was divided into two phases: induction and maintenance. We defined the transition from induction to maintenance by a Ce value that corresponded to a depth of anaesthesia suitable for suspension laryngoscopy. Maintenance commenced when the Ce = Ce DL + 1, where the Ce DL was the Ce at which successful non-reactive direct laryngoscopy occurred. The maintenance phase continued until anaesthesia was completed. The SVTCI Cp-Ce=1 conduct of anaesthesia typically proceeded in the following sequence:
1.Induction • A pre-induction protocol of intravenous glycopyrrolate 0.2 mg (to reduce secretions), metoclopramide 20 mg and lignocaine 50 mg (to reduce propofol injection pain) was given; • no other sedatives or opioids were given before or during the induction; • the patients were positioned 10 o -20 o reverse Trendelenburg;
• 100% oxygen was applied via a standard mask/circle circuit;
• propofol TCI was commenced, as per the above protocol;
• a nasopharyngeal airway (NPA) was commonly placed at a Ce of 2-3 μg/ml, after Co-Phenylcaine Forte® nasal spray (lignocaine 5% + phenylephrine 0.5%, ENT Technologies Pty Ltd, Hawthorne East, Australia) was applied into the nares; • direct laryngoscopy was performed at a Ce of 5-6 μg/ ml and Co-Phenylcaine Forte was sprayed onto the vocal cords; • the mask/circuit was reapplied until the Ce increased by a further 1 μg/ml and regular ventilation was re-confirmed.
2.Maintenance
• Suspension laryngoscopy by the surgeon occurred at a Ce of 6-7 μg/ml; • oxygen was then supplied nasally via a NPA or a cuffless tube (inserted just beyond the uvula), which was connected to the circuit allowing an adjustable FiO 2
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; • respiratory rate monitoring occurred manually or via modified capnography (the gas sampling line was attached to a metal cannula connected to the suspension laryngoscope); • low dose remifentanil (eg 0.05 μg/kg/minute) was commenced as necessary to assist with vocal cord immobility during laser surgery; • the surgery would proceed tubeless or a tracheal tube would be placed by the surgeon if required; • after the surgery was completed and the suspension laryngoscope was removed the circuit was reconnected to a facemask which was applied to the patient, the anaesthetic infusions were ceased, and a small bolus of fentanyl was given as required for postoperative analgesia (e.g. 25 μg); • the patient was awoken in the sitting position and then transferred to the post anaesthesia care unit when awake.
Other methods of SVTCI
SVTCI Alfentanil involved the use of Marsh pharmacokinetic model TCI, but with alfentanil mixed into the propofol syringe (typically with a concentration of 20-40 μg/ml).
SVTCI Remi involved the concurrent use of a separate remifentanil infusion (Minto pharmacokinetic model), which commenced with or prior to the propofol TCI.
SVTCI Other involved a heterogeneous group of propofol-only SVTCI methods that did not use the Cp -Ce = 1 formula.
Outcomes
The analyses of techniques and outcomes were divided into induction and maintenance phases. The main outcome measures were the rate of technique failure or conversion, conditions during the induction and maintenance phases, and complications. Technique failure was defined as a deviation from a primary airway or ventilation technique due to a problem or complication, even if temporary. Technique conversion was defined as the complete change to a secondary airway or ventilation technique due to the inability to continue using the primary technique. Conditions during the induction and maintenance phases were described by reactivity during airway instrumentation (peripheral movement, coughing, laryngospasm) or operative surgery (vocal cord position and movement). Complications included apnoea (no respiratory effort for 60 seconds), complete airway obstruction, hypoxaemia (SpO 2 <90%), hypercarbia (end-tidal CO 2 >60 mmHg), regurgitation, aspiration, lower airway soiling by blood, or airway fire. Haemodynamic data were collected including the frequency of vasopressor use.
Descriptive statistics, including mean and standard deviation (SD) were used for continuous variables and proportions were used for categorical variables.
Results
In total, 2201 ENT surgical cases were performed between November 2011 and February 2015. Of these, 285 were elective microlaryngoscopy cases, which were all included in the analysis ( Figure 2 ). The most common induction techniques were conventional intravenous induction and neuromuscular blockade (IVNMB, 202, 71%) and SVTCI (79, 28%). Awake techniques were used in only two cases, and inhalational induction in two cases. Closed anaesthesia with mechanical ventilation (MV) was the most common technique during the maintenance phase (199, 77%). After induction using SVTCI, 12 were intubated and mechanically ventilated, two had a tracheostomy, and three were ventilated intermittently, leaving 62 patients who maintained SV using TCI throughout. The SVTCI induction methods were classified into four different subtypes: SVTCI Cp-Ce=1 (32, 40%), SVTCI Alfentanil (30, 38%), SVTCI Remi (6, 7%), and SVTCI other (11, 14%) . The most common surgical pathology for the SVTCI cases was subglottic stenosis (35). Other pathologies included vocal cord palsies or other lesions, arytenoid prolapse or adhesion, and cancers. The most common surgical procedures were balloon dilatation (27) , biopsy (14) , and use of laser (14) .
For the 32 cases in the SVTCI Cp-Ce=1 subgroup, the mean (SD) Cpt starting dose was 2.3 (0.75) μg/ml, which was incrementally increased by a mean (SD) of 0.8 (0.26) μg/ml throughout the induction (Table 1) . Loss of consciousness occurred at a mean (SD) Ce of 1.2 (0.59) μg/ml. Most cases had a nasopharyngeal airway (81%), which was inserted 
Induction Phase
In the SVTCI Cp-Ce=1 group there was only one technique failure, due to regurgitation that caused laryngospasm and hypoxaemia midway during the induction (Table 2 ). This was successfully converted to assisted ventilation after neuromuscular blockade. There were no cases of apnoea. One patient with neurologic disease hypoventilated early during the induction and responded to a reduction in propofol Cpt. Respiratory rates in all other cases remained above 8 /minute. The respiratory rates were also preserved at the Ce MAX with a mean (SD) of 20 /minute. There were two episodes of coughing that occurred early and were self-limiting. Two episodes of minor laryngospasm occurred during direct laryngoscopy. One of these was directly related to 10% lignocaine being sprayed onto the vocal cords and both resolved spontaneously. Direct laryngoscopy in the remaining cases was well tolerated with only one episode of minor peripheral reactivity. There was one other case of hypoxaemia that occurred with the use of Heliox 28% early in the induction. This was brief and resolved with the application of 100% inspired oxygen. The mean oxygen saturations for all cases remained above 96% throughout the induction.
The other SVTCI subgroups were associated with more technique failures (7%-17%) due to apnoea (SVTCI Alfentanil and SVTCI Remi groups) and hypoxaemia (SVTCI Other group) requiring assisted ventilation. One SVTCI Alfentanil case was converted to a propofol-only technique. Another SVTCI Other case required suxamethonium to control excessive coughing associated with excessive secretions, but subsequently returned to spontaneous ventilation. Hypoxaemia was most frequent in the SVTCI Alfentanil group (n=6, 20%).
Maintenance phase
Anaesthesia for the maintenance phase was successful in 24 (92.3%) of the SVTCI Cp-Ce=1 cases (Table 3) . Most of these cases involved airway obstruction (61.5%) and many operated with laser (30.8%) in a low FiO 2 environment (38.5%). Difficult BMV n/a n/a n/a n/a 3 (1.5) n/a n/a n/a 0 n/a n/a n/a n/a Barotrauma n/a n/a n/a n/a 2 (66.7) 0 0 There were two (7.7%) technique failures associated with hypoxaemia. The first of these was due to oxygen delivery failure caused by a kinked nasopharyngeal airway, and required conversion to intermittent ventilation. The second failure resulted from apnoea associated with remifentanil use in a patient with poor cardiac reserve. Intermittent ventilation was briefly used to restore normal oxygenation until SV returned after the remifentanil was ceased. Hypoxaemia occurred in eight other cases (38% in total); however, all of these episodes were brief and controllable. Oxygen saturation levels of 88% were tolerated in three laser cases using a lower FiO 2 . The remaining episodes were related to surgical occlusion of the airway during suspension laryngoscopy insertion/removal or balloon dilatation and were all self-limiting. One further case of apnoea occurred during the emergence phase without hypoxaemia and resolved with a reduction in anaesthetic depth. Suspension laryngoscopy was very well tolerated in all cases with no episodes of reactivity or coughing. The other SVTCI subgroups were associated with more technique failures (12.5%-50%) and more conversions (12.5%-33.3%) during the maintenance phase. In the SVTCI Alfentanil group, two cases of hypoxaemia were converted to IV and two cases of excessive reactivity required intubation to facilitate the surgery. In the SVTCI Remi group, two cases of hypoxaemia were converted to IV during the surgery and one case of severe hypoxaemia required assisted mask ventilation after suspension laryngoscope withdrawal. Overall, hypoxaemia occurred more frequently in the SVTCI Alfentanil group (40%) and in all cases of the SVTCI Remi group. One case in the SVTCI Other group was converted to SVTCI Alfentanil after excessive reactivity.
In the non-SVTCI techniques, jet ventilation was associated with the most failures (33.3%) and the most severe complications overall. Two (66.7%) cases of vocal cord barotrauma occurred, which required emergent intubation and ICU admission. These cases were also associated with hypoxaemia, one of which was severe (SpO 2 <80%) and persisted throughout the procedure. In the mechanical ventilation group, three technique failures (1.5%) were caused by inadequate airway exposure and converted to other modalities. Most complications in the mechanical ventilation group occurred during the emergence phase. There were 44 (21.7%) cases of hypoxaemia, with 34 related to emergence or extubation. Most of these were brief and self-limiting; however, one case required reintubation and four others required assisted ventilation. Seven other critical extubation events that required specific intervention were identified (6% in total) including four cases of laryngospasm, one case of severe bronchospasm and two cases of residual curarisation. Six cases of hypoxaemia during the procedure involved a low FiO 2 during laser. One of these was associated with temporary ventilation failure due to cuff damage of the laser-resistant tube. Suspension laryngoscopy was associated with reactivity requiring intervention in four (2%) cases and there was one case of significant regurgitation without aspiration. Hypoxaemia occurred in one intermittent ventilation case (33.3%).
Haemodynamics for the SVTCI Cp-Ce=1 cases remained stable throughout the induction and maintenance phases. The mean lowest mean arterial pressure (MAP) was 89 mmHg and vasopressors were used in only four cases (12.5%). Heart rate was highest in the SVTCI Cp-Ce=1 group, while MAP was similar for all of the SVTCI subgroups. The mean minimum MAP in the MV group was 66 mmHg, which was lower than the SVTCI groups (72 mmHg). Overall, vasopressors were used in nine (11%) of the SVTCI cases and 73 (35%) of the non-SVTCI cases.
Discussion
We performed a retrospective audit of the airway and ventilation management for 285 adult microlaryngoscopy cases at a tertiary hospital after a new method of SV using propofol TCI (SVTCI Cp-Ce=1 ) was introduced into routine practice. Overall, conventional intubation with mechanical ventilation was the most commonly used technique followed by SVTCI as the main alternative. Our ratio of open/closed techniques was similar to that reported by Klussmann et al 17 , although we had replaced JV with SVTCI. This audit allowed us to separate the induction and maintenance phases for microlaryngoscopy and analyse problems associated with each phase for all techniques. Our audit found that many of our outcome measures for SVTCI Cp-Ce=1 were comparable to or more favourable than the alternative open and closed techniques.
The demographics and surgical pathology in our SVTCI groups were generally similar to those reported in previous microlaryngoscopy series 8, 9, 17, 18 . We found that SVTCI techniques had been used more often in complicated patients. Airway compromise, mostly due to subglottic stenosis, was more common in our SVTCI groups, compared to our IVNMB/MV group. Our SVTCI Cp-Ce=1 patients also had higher body mass indices or weight than in many previous studies of microlaryngoscopy techniques 9, 18, 19 . One of the major findings of this audit was that our SVTCI Cp-Ce=1 method appeared to maintain spontaneous respiration with minimal apnoeic episodes, even at deep levels of anaesthesia (i.e. Ce MAX ). This was more successful than the SVTCI Alfentanil and SVTCI Remi groups and most of the reports in previously published spontaneous ventilation series 14, 18, 19, 20 . We believe several factors were responsible for the successful ventilation in the SVTCI Cp-Ce=1 group. Firstly, we reduced the size of the initial bolus, because high rates of apnoea (40-100%) were associated with large initial propofol doses (2 mg/kg) in previous spontaneous ventilation series. We achieved this by using Marsh model Cpt TCI, using a maximum input weight of 100 kg and selecting a starting Cpt dose of 2-3 μg/ml. Kiyama et al suggested that targeting the effect-site caused more apnoea from overshoot compared to plasma-site targeting 20 . Apnoea rates of 15% have been reported using this approach by Passot et al 21 
.
Limiting our weight to 100 kg approximated the adjusted body weight in our obese males, which has been shown to perform well in the Marsh model 22 . Correct selection of the starting Cpt is important. A starting Cpt of 4 μg/ml or greater was associated with high rates of apnoea (>40%) in previous studies 23, 24 . Keeping our Cpt below this along with incremental increases of 0.5-1 μg/ml was associated with respiratory rates at or above 8 /minute during all of the induction phases. Secondly using the Cp -Ce = 1 formula increased the depth of anaesthesia in a controlled stepwise manner that minimised drug level overshoot. We found that there was an acceptable balance between the speed of the induction and the risk of apnoea. We also found consistent and reproducible Ce endpoints to guide airway manipulations. Our mean induction time was 17.2 minutes, which although longer than a standard intravenous induction, was similar to the jet ventilation series reported by Orloff et al (range 5-30 minutes) 5 . Thirdly, we minimised the use of opioids, especially during the induction phase. Multiple parameters of ventilation were worse in the SVTCI Alfentanil and SVTCI Remi groups. We attributed this to the respiratory suppressant effects of potent opioids co-infused from the start of the induction. These techniques were both associated with failed inductions due to apnoea, and lower respiratory rates (20% <8 /minute). One SVTCI Alfentanil failure occurred when the depth of anaesthesia was insufficient to tolerate laryngoscopy, yet could not be deepened further due to apnoea. This type of problem was recognised by the NAP 4 audit 25 . Remifentanil was implicated in the only maintenance apnoea of the SVTCI Cp-Ce=1 group despite being used as a low dose infusion as recommended by previous dose-response studies 26 . Cautious remifentanil dosing has been recommended to avoid respiratory depression due to its synergism with propofol 27 . The audit results support our hypothesis that the SVTCI Cp-Ce=1 technique would provide excellent operating conditions. Suspension laryngoscopy was well tolerated in all cases with no episodes of reactivity or laryngospasm. The vocal cords were abducted and were immobile or only moving minimally for all cases, which provided unimpeded and uninterrupted surgical access to the airway. Nekhendzy et al have stated that precision surgery is difficult or impossible using spontaneous ventilation. However, our surgeons were able to successfully perform a range of laryngeal framework and phonomicrosurgical procedures, similar to those reported in previous microlaryngoscopy series, including the use of laser 1, 8, 9, 17, 18 . In contrast, reactivity occurred more often when using the other techniques. It occurred in four (2%) of the mechanical ventilation cases, but was most severe in the SVTCI Alfentanil group, resulting in two (9%) cases of technique failure and conversion. We found this was particularly surprising as neuromuscular blockade with mechanical ventilation is considered the gold standard in airway control and the co-infusion of opioids is designed to minimise the stimulation of microlaryngoscopy. The surgery was also not possible in three (1.5%) of the mechanical ventilation cases due to inadequate airway access, which highlighted the potential disadvantage of a closed airway during microlaryngoscopy in some patients. Interruption of laser surgery for re-oxygenation was required during two (33%) of the SVTCI Remi cases.
Our results demonstrated stable haemodynamics in the SVTCI groups. In the SVTCI Cp-Ce=1 group the MAP decreased by only 10% during the induction and had returned to the preinduction baseline at the CeMAX. This stability was greater than that reported by Aun et al and Rabadi et al, who had both used a 2 mg/kg induction bolus of propofol 18, 28 . Overall, it appeared that there was more cardiovascular depression in the non-SVTCI groups. Blood pressure was lower in the MV and IV groups compared to the SVTCI groups and the MV group also received three times the amount of vasopressor support. These findings are in contrast to previous reports of cardiovascular depression associated with spontaneous ventilation techniques 1, 2, 6 . We found that each anaesthetic technique was associated with its own specific type and pattern of complications, which was in keeping with their known disadvantages. The most severe complications occurred in the JV group, with two cases (66%) of barotrauma requiring urgent intubation on emergence and ICU admission. Barotrauma is a recognised serious complication of JV, which has been reported in many series and has contributed to the increased use of SVTCI at our institution 8, 9, 29 . The high incidence in our series may reflect the infrequent use of this technique at our institution and may not represent the experience in other centres.
Not surprisingly, most complications in the IVNMB and MV groups were mainly related to intubation and extubation, respectively. More events occurred during extubation, which is recognised as a high-risk period 30, 31 . The prevalence of difficult mask ventilation, intubation and reintubation was consistent with previous series 30, 32, 33 . Of note, the incidence of failed intubation was 22% when the airway was compromised.
The one major complication in the SVTCI Cp-Ce=1 group resulted from regurgitation, laryngospasm, and hypoxaemia during the induction. An open unprotected airway is a disadvantage in the setting of regurgitation and this event prompted our routine use of metoclopramide to try to reduce its occurrence.
Importantly, there were no cases of airway failure caused by worsening or complete airway obstruction during the SVTCI Cp-Ce=1 inductions. Despite spontaneous ventilation being described as an inferior technique for subglottic stenosis by Nouraei et al and Patel et al 13, 25 , it was successfully used in 10 cases in our series. We prefer the traditional approach of spontaneous ventilation due to the margin of safety it offers in the face of limited surgical rescue options 7, 11 . Overall, the most common complication was hypoxaemia. Our rates were generally higher than those reported in previous microlaryngoscopy series. This may have been an "oversampling" effect due to our use of a continuous automated recording system. We reported all minor and brief episodes, of which some may have been spurious or not clinically significant and not included in the previous series. This sampling effect was recognised by Ehrenfeld et al who also found high rates of hypoxaemia that we consider equivalent to our MV group 34 .
Most of the hypoxaemia in the SVTCI Cp-Ce=1 group was caused by brief and controllable events. Importantly, no episodes of severe hypoxaemia occurred even when the FiO 2 was <30%, which allowed uninterrupted and safe laser surgery.
There are several limitations to this study and all our findings must be interpreted with caution. The audit was retrospective and observational. The results were dependent on the accuracy and completeness of data entered into the electronic record during the case and then collected from the electronic records. Although data in the SVTCI Cp-Ce=1 group was considered complete, data from the other SVTCI and non-SVTCI groups was often incomplete. Although the automatically recorded data (e.g. SpO 2 , haemodynamic observations) was complete for these other groups, data that required manual entry (e.g. propofol dosing, surgical conditions or explanations of respiratory events and complications) was often incomplete. For this reason, only general impressions can be made about the non-SVTCI Cp-Ce=1 groups, and these would require confirmation in more formal prospective studies. Our findings also apply to a single centre only, and different results might be expected in other centres or in departments with different preferences or different levels of experience with the various techniques. Most importantly, this was not a formal study, only an intradepartmental audit, which at best can be hypothesis-generating. Despite this, there is little information available on spontaneous ventilation techniques during microlaryngoscopy, and other clinicians might find our experiences with our relatively novel SVTCI CpCe=1 technique of interest. In summary, in an intradepartmental audit we found that a new method of SVTCI (SVTCI Cp-Ce=1 ) that we had introduced into our practice appeared to be a satisfactory technique for microlaryngoscopy. While it appeared to have several advantages over other spontaneous ventilation techniques, a prospective randomised controlled trial would be required for a formal comparison.
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